NYSE US 100

NYSE US 100 handeln
19.171,88 PKT -36,58 PKT -0,19 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE US 100-Werten

Datum Rating Analyst
07.03.12 American Express equal-weight Barclays Capital
07.03.12 Lockheed Martin outperform RBC Capital Markets
06.03.12 ConocoPhillips sell UBS AG
06.03.12 Halliburton outperform RBC Capital Markets
05.03.12 Coca-Cola neutral UBS AG
05.03.12 American International Group (AIG) neutral UBS AG
05.03.12 Target buy UBS AG
05.03.12 Johnson Johnson kaufen Die Actien-Börse
02.03.12 Caterpillar buy Sarasin Research
01.03.12 Bayer halten Hamburger Sparkasse AG (Haspa)
01.03.12 ExxonMobil buy UBS AG
01.03.12 Abbott Laboratories buy UBS AG
01.03.12 Carnival buy UBS AG
01.03.12 ExxonMobil halten Independent Research GmbH
01.03.12 JPMorgan Chase overweight Barclays Capital
01.03.12 Baxter International outperform RBC Capital Markets
01.03.12 Wells Fargo overweight Barclays Capital
01.03.12 Chevron buy Deutsche Bank Securities
29.02.12 Bayer halten Independent Research GmbH
29.02.12 Bayer halten Norddeutsche Landesbank (Nord/LB)
29.02.12 Allstate equal-weight Barclays Capital
28.02.12 Transocean outperform RBC Capital Markets
28.02.12 Lowes Companies outperform RBC Capital Markets
28.02.12 Bayer buy Sarasin Research
28.02.12 Lowes Companies buy UBS AG
28.02.12 Baxter International buy UBS AG
28.02.12 Boeing neutral UBS AG
28.02.12 Citigroup overweight Barclays Capital
28.02.12 Transocean neutral Credit Suisse Group
28.02.12 Lowes Companies outperform Credit Suisse Group
28.02.12 Procter Gamble halten Independent Research GmbH
28.02.12 Bayer halten National-Bank AG
28.02.12 Walmart equal-weight Barclays Capital
28.02.12 Chevron halten Independent Research GmbH
27.02.12 Bank of America neutral UBS AG
27.02.12 Procter Gamble neutral UBS AG
27.02.12 Procter Gamble buy Sarasin Research
27.02.12 Target overweight Barclays Capital
27.02.12 Transocean neutral Sarasin Research
27.02.12 U.S. Bancorp overweight Barclays Capital